Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: CISPLATIN - ADVERSE EFFECTS, 1970. Treffer: 18

2023

Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

2021

Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Dulz, S; Asselborn, NH; Dieckmann, KP; Matthies, C; Wagner, W; Weidmann, J; Seidel, C; Oing, C; Berger, LA; Alsdorf, W; Mankichian, B; Meyer, C; Vetterlein, MW; Gild, P; Ludwig, TA; Soave, A; Schriefer, P; Becker, A; Ahyai, SA; Oechsle, K; Bokemeyer, C; Wagenfeld, L; Fisch, M; Hartmann, M; Chun, FK; Kluth, LA Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer.
J Cancer Res Clin Oncol. 2017; 143(7):1319-1325 Doi: 10.1007/s00432-017-2384-8
Web of Science PubMed FullText FullText_MUG

 

Ferrari, S; Bielack, SS; Smeland, S; Longhi, A; Egerer, G; Sundby Hall, K; Donati, D; Kevric, M; Brosjö, O; Comandone, A; Werner, M; Monge, O; Palmerini, E; Berdel, WE; Bjerkehagen, B; Paioli, A; Lorenzen, S; Eriksson, M; Gambarotti, M; Tunn, PU; Jebsen, NL; Cesari, M; von Kalle, T; Ferraresi, V; Schwarz, R; Bertulli, R; Kasparek, AK; Grignani, G; Krasniqi, F; Sorg, B; Hecker-Nolting, S; Picci, P; Reichardt, P EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017; 104(1):30-36 Doi: 10.5301/tj.5000696
Web of Science PubMed FullText FullText_MUG

 

Račkauskas, R; Zhou, D; Ūselis, S; Strupas, K; Herr, I; Schemmer, P Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
Oncol Rep. 2017; 37(6):3660-3666 Doi: 10.3892/or.2017.5622 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Keil, F; Selzer, E; Berghold, A; Reinisch, S; Kapp, KS; De Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsäßer, W; Kainz, H; Riedl, R; Kopp, M; Kornek, G Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
Eur J Cancer. 2013; 49(2):352-359 Doi: 10.1016/j.ejca.2012.08.004
Web of Science PubMed FullText FullText_MUG

 

Olaussen, KA; Adam, J; Vanhecke, E; Vielh, P; Pirker, R; Friboulet, L; Popper, H; Robin, A; Commo, F; Thomale, J; Kayitalire, L; Filipits, M; Le Chevalier, T; André, F; Brambilla, E; Soria, JC PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Lung Cancer. 2013; 80(2):216-222 Doi: 10.1016/j.lungcan.2013.01.014 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Henke, M; Alfonsi, M; Foa, P; Giralt, J; Bardet, E; Cerezo, L; Salzwimmer, M; Lizambri, R; Emmerson, L; Chen, MG; Berger, D Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
J CLIN ONCOL. 2011; 29(20): 2815-2820. Doi: 10.1200/JCO.2010.32.4103 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Le, QT; Kim, HE; Schneider, CJ; Murakozy, G; Skladowski, K; Reinisch, S; Chen, Y; Hickey, M; Mo, M; Chen, MG; Berger, D; Lizambri, R; Henke, M Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
J CLIN ONCOL. 2011; 29(20): 2808-2814. Doi: 10.1200/JCO.2010.32.4095 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2006

Greimel, ER; Bjelic-Radisic, V; Pfisterer, J; Hilpert, F; Daghofer, F; du Bois, A; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
J CLIN ONCOL. 2006; 24(4): 579-586. Doi: 10.1200/JCO.2005.02.4067 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wilkinson, PM; Antonopoulos, M; Lahousen, M; Lind, M; Kosmidis, P; EPO-INT-45 Study Group Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial.
Br J Cancer. 2006; 94(7):947-954 Doi: 10.1038/sj.bjc.6603004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Petru, E; Petru, C; Benedicic, Ch Re: Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.
GYNECOL ONCOL. 2005; 96(2): 559; author reply 559-559; author reply 560. Doi: 10.1016/j.ygyno.2004.09.060
Web of Science PubMed FullText FullText_MUG

 

2003

Dalpiaz, O; al Rabi, N; Galfano, A; Martignoni, G; Ficarra, V; Artibani, W Small cell carcinoma of the bladder: a case report and a literature review.
Arch Esp Urol. 2003; 56(2):197-202 (- Case Report)
PubMed

 

Ploner, F; Jakesz, R; Hausmaninger, H; Kolb, R; Stierer, M; Fridrik, M; Steindorfer, P; Gnant, M; Haider, K; Mlineritsch, B; Tschurtschenthaler, G; Steger, G; Seifert, M; Kubista, E; Samonigg, H; Austrian Breast And Colorectal Cancer Study Group Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
Onkologie. 2003; 26(2):115-119 Doi: 10.1159/000069831
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2001

Thurnher, D; Kletzmayr, J; Formanek, M; Quint, C; Czerny, C; Burian, M; Kornek, G Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
Oncology. 2001; 61(2):143-146 Doi: 10.1159/000055365 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1998

Goedhals, L; Heron, JF; Kleisbauer, JP; Pagani, O; Sessa, C; Giger, K; Cavalli, F; Ludwig, C; Aapro, M; Bleiberg, H; De Wash, G; Dicato, M; Tagnon, A; Vanstraelen, D; Vindevoghel, A; Abratt, R; Falkson, G; Barley, V; Carmichael, J; Coleman, R; Davidson, N; Grieve, R; Harper, P; Roberts, J; Rustin, G; Naman, H; Schneider, M; Noble, A; Netter, P; Cupissol, D; Balmes, P; Cals, L; Khayat, D; Catimel, G; Dutin, JP; Boufette, P; Adenis, L; Misset, J; Collery, P; Nouvet, G; Chavaillon, JM; Blanchon, F; Poirier, R; Arnaud, A; Lecaer, H; Carles, P; Muir, J; Bonnaud, F; Marqueste, L; Clavier, J; Guerin, J; Taytard, A; Keizer, H; Nortier, J; Slee, P; Wils, J; Rodenburg, C; Burghouts, J; De Wit, R; Garcia-Giron, C; Jimenez-Lacave, A; Cruz-Hernandez, J; Massuti-Sureda, B; Hans, K; Fuchs, R; Kriegmair, M; Schuller, J; Lahousen, M; Pannuti, F; Monfardini, S; Nilsson, S Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: a double-blind, placebo-controlled, comparative study.
Ann Oncol. 1998; 9(6):661-666 Doi: 10.1023/A:1008256115221 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum